Aquilo Capital Management, LLC

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0001591986

Type: FundHoldings: 13Value: $55.8MLatest: 2025Q1

Aquilo Capital Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 13 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ARWR",
  "RGNX",
  "ARVN",
  "BCYC",
  "IMTX",
  "ACET",
  "KYMR",
  "RPTX",
  "ZYME",
  "AMGN",
  "PTGX",
  "DTIL",
  "BPMC"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 13
Total Value: 55776888
Accession Number: 0001591986-25-000004
Form Type: 13F-HR
CIK: aquilo-capital-management
Manager Name: Aquilo-Capital-Management

Data Enrichment

100% identified

13 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

13 positions • $55.8M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

AMGEN INC

AMGN|031162100

Shares:60.0K

Value:$18.7M

% of Portfolio:33.5% ($18.7M/$55.8M)

Blueprint Medicines Corp

BPMC|09627Y109

Shares:83.9K

Value:$7.4M

% of Portfolio:13.3% ($7.4M/$55.8M)

ARROWHEAD PHARMACEUTICALS, INC.

ARWR|04280A100

Shares:550.1K

Value:$7.0M

% of Portfolio:12.6% ($7.0M/$55.8M)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:81.7K

Value:$4.0M

% of Portfolio:7.1% ($4.0M/$55.8M)

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:138.5K

Value:$3.8M

% of Portfolio:6.8% ($3.8M/$55.8M)

PRECISION BIOSCIENCES INC

DTIL|74019P207

Shares:726.1K

Value:$3.5M

% of Portfolio:6.2% ($3.5M/$55.8M)

ARVINAS, INC.

ARVN|04335A105

Shares:360.8K

Value:$2.5M

% of Portfolio:4.5% ($2.5M/$55.8M)

REGENXBIO Inc.

RGNX|75901B107

Shares:271.3K

Value:$1.9M

% of Portfolio:3.5% ($1.9M/$55.8M)

Adicet Bio, Inc.

ACET|007002108

Shares:2.5M

Value:$1.9M

% of Portfolio:3.3% ($1.9M/$55.8M)

BICYCLE THERAPEUTICS PLC

BCYC|088786108

Shares:171.7K

Value:$1.5M

% of Portfolio:2.6% ($1.5M/$55.8M)

Immatics N.V.

IMTX|N44445109

Shares:304.9K

Value:$1.4M

% of Portfolio:2.5% ($1.4M/$55.8M)

Repare Therapeutics Inc.

RPTX|760273102

Shares:1.3M

Value:$1.3M

% of Portfolio:2.3% ($1.3M/$55.8M)

Zymeworks Inc.

ZYME|98985Y108

Shares:84.5K

Value:$1.0M

% of Portfolio:1.8% ($1.0M/$55.8M)

Instrument	Shares		Other Manager	Value	% of Portfolio
AMGEN INC(AMGNcusip031162100)	60.0K	QoQ +140.00% (+35.0K) YoY NEW(+60.0K)	All Managers (Combined)	$18.7M	33.5% ($18.7M/$55.8M)	QoQ +186.87% (+$12.2M) YoY NEW(+$18.7M)
Blueprint Medicines Corp(BPMCcusip09627Y109)	83.9K	QoQ -35.24% (-45.7K) YoY -53.92% (-98.2K)	All Managers (Combined)	$7.4M	13.3% ($7.4M/$55.8M)	QoQ -34.28% (-$3.9M) YoY -57.00% (-$9.9M)
ARROWHEAD PHARMACEUTICALS, INC.(ARWRcusip04280A100)	550.1K	QoQ +633.50% (+475.1K) YoY -39.44% (-358.3K)	All Managers (Combined)	$7.0M	12.6% ($7.0M/$55.8M)	QoQ +397.06% (+$5.6M) YoY -73.02% (-$19.0M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	81.7K	QoQ +6.65% (+5.1K) YoY NEW(+81.7K)	All Managers (Combined)	$4.0M	7.1% ($4.0M/$55.8M)	QoQ +33.62% (+$994.2K) YoY NEW(+$4.0M)
Kymera Therapeutics, Inc.(KYMRcusip501575104)	138.5K	QoQ -24.52% (-45.0K) YoY -64.36% (-250.2K)	All Managers (Combined)	$3.8M	6.8% ($3.8M/$55.8M)	QoQ -48.64% (-$3.6M) YoY -75.73% (-$11.8M)
PRECISION BIOSCIENCES INC(DTILcusip74019P207)	726.1K	QoQ +35.38% (+189.8K) YoY +88.39% (-340.7K)	All Managers (Combined)	$3.5M	6.2% ($3.5M/$55.8M)	QoQ +69.49% (+$1.4M) YoY -33.72% (-$1.8M)
ARVINAS, INC.(ARVNcusip04335A105)	360.8K	QoQ +9.73% (-32.0K) YoY -11.09% (-45.0K)	All Managers (Combined)	$2.5M	4.5% ($2.5M/$55.8M)	QoQ -59.81% (-$3.8M) YoY -84.88% (-$14.2M)
REGENXBIO Inc.(RGNXcusip75901B107)	271.3K	QoQ -21.65% (-75.0K) YoY -70.06% (-634.9K)	All Managers (Combined)	$1.9M	3.5% ($1.9M/$55.8M)	QoQ -27.53% (-$737.1K) YoY -89.84% (-$17.2M)
Adicet Bio, Inc.(ACETcusip007002108)	2.5M	QoQ -2.96% (-75.0K) YoY NEW(+2.5M)	All Managers (Combined)	$1.9M	3.3% ($1.9M/$55.8M)	QoQ -23.84% (-$580.6K) YoY NEW(+$1.9M)
BICYCLE THERAPEUTICS PLC(BCYCcusip088786108)	171.7K	QoQ -22.62% (-50.2K) YoY NEW(+171.7K)	All Managers (Combined)	$1.5M	2.6% ($1.5M/$55.8M)	QoQ -53.07% (-$1.6M) YoY NEW(+$1.5M)
Immatics N.V.(IMTXcusipN44445109)	304.9K	QoQ -18.45% (-69.0K) YoY NEW(+304.9K)	All Managers (Combined)	$1.4M	2.5% ($1.4M/$55.8M)	QoQ -48.27% (-$1.3M) YoY NEW(+$1.4M)
Repare Therapeutics Inc.(RPTXcusip760273102)	1.3M	QoQ 0.00% (-0) YoY +104.29% (-660.4K)	All Managers (Combined)	$1.3M	2.3% ($1.3M/$55.8M)	QoQ -24.74% (-$419.3K) YoY -57.23% (-$1.7M)
Zymeworks Inc.(ZYMEcusip98985Y108)	84.5K	QoQ NEW(+84.5K) YoY NEW(+84.5K)	All Managers (Combined)	$1.0M	1.8% ($1.0M/$55.8M)	QoQ NEW(+$1.0M) YoY NEW(+$1.0M)